Price T Rowe Associates Inc Johnson & Johnson Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,377,533 shares of JNJ stock, worth $1.45 Billion. This represents 0.14% of its overall portfolio holdings.

Number of Shares

8,377,533

Previous 10,106,073 17.1%

Holding current value

$1.45 Billion

Previous $1.68 Billion 23.65%

% of portfolio

0.14%

Previous 0.21%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$146.36 - $159.82 $253 Million - $276 Million	-1,728,540 Reduced 17.1%	8,377,533 $1.28 Billion
Q1 2025 May 14, 2025	SELL	$142.06 - $167.7 $878 Million - $1.04 Billion	-6,177,098 Reduced 37.94%	10,106,073 $1.68 Billion
Q4 2024 Feb 14, 2025	SELL	$143.34 - $165.86 $1.27 Billion - $1.47 Billion	-8,877,281 Reduced 35.28%	16,283,171 $2.35 Billion
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $36.6 Million - $42.1 Million	251,257 Added 1.01%	25,160,452 $4.08 Billion
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $444 Million - $485 Million	3,074,836 Added 14.08%	24,909,195 $3.64 Billion
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $487 Million - $511 Million	3,139,499 Added 16.79%	21,834,359 $3.45 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $33.9 Million - $37 Million	232,738 Added 1.26%	18,694,860 $2.93 Billion
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $1.47 Billion - $1.65 Billion	-9,453,413 Reduced 33.86%	18,462,122 $2.88 Billion
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $167 Million - $180 Million	1,081,734 Added 4.03%	27,915,535 $4.62 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $369 Million - $441 Million	-2,443,973 Reduced 8.35%	26,833,801 $4.16 Billion
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $617 Million - $692 Million	3,849,148 Added 15.14%	29,277,774 $5.17 Billion
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $130 Million - $145 Million	805,831 Added 3.27%	25,428,626 $4.15 Billion
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $658 Million - $728 Million	3,912,430 Added 18.89%	24,622,795 $4.37 Billion
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $983 Million - $1.12 Billion	6,215,994 Added 42.89%	20,710,365 $3.67 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $107 Million - $118 Million	-683,126 Reduced 4.5%	14,494,371 $2.48 Billion
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $2.72 Million - $3.02 Million	16,836 Added 0.11%	15,177,497 $2.45 Billion
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $32.1 Million - $34.5 Million	-201,387 Reduced 1.31%	15,160,661 $2.5 Billion
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $287 Million - $320 Million	-1,874,856 Reduced 10.88%	15,362,048 $2.52 Billion
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $2.36 Billion - $2.71 Billion	17,236,904 New	17,236,904 $2.71 Billion

Others Institutions Holding JNJ

# of Institutions

4,624

Shares Held

1.76B

Call Options Held

22.8M

Put Options Held

16.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $452B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Johnson & Johnson Transaction History